Twist Bioscience Corp. (TWST)
188.67
+0.62
(+0.33%)
USD |
NASDAQ |
Oct 02, 16:00
189.79
+1.12
(+0.59%)
After-Hours: 20:00
Twist Bioscience Price to Book Value : 26.53 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 26.53 |
| October 01, 2026 | 26.44 |
| September 30, 2026 | 27.17 |
| September 29, 2026 | 26.17 |
| September 28, 2026 | 25.25 |
| September 25, 2026 | 25.71 |
| September 24, 2026 | 25.88 |
| September 23, 2026 | 22.29 |
| September 22, 2026 | 23.14 |
| September 21, 2026 | 23.32 |
| September 18, 2026 | 23.48 |
| September 17, 2026 | 21.87 |
| September 16, 2026 | 20.12 |
| September 15, 2026 | 19.42 |
| September 14, 2026 | 18.95 |
| September 11, 2026 | 17.89 |
| September 10, 2026 | 17.84 |
| September 09, 2026 | 17.65 |
| September 08, 2026 | 18.01 |
| September 04, 2026 | 17.54 |
| September 03, 2026 | 18.10 |
| September 02, 2026 | 18.42 |
| September 01, 2026 | 18.57 |
| August 31, 2026 | 19.54 |
| August 28, 2026 | 19.88 |
| Date | Value |
|---|---|
| August 27, 2026 | 21.53 |
| August 26, 2026 | 21.10 |
| August 25, 2026 | 21.29 |
| August 24, 2026 | 19.80 |
| August 21, 2026 | 20.47 |
| August 20, 2026 | 19.17 |
| August 19, 2026 | 20.02 |
| August 18, 2026 | 16.32 |
| August 17, 2026 | 17.49 |
| August 14, 2026 | 16.67 |
| August 13, 2026 | 17.62 |
| August 12, 2026 | 17.61 |
| August 11, 2026 | 17.31 |
| August 10, 2026 | 17.56 |
| August 07, 2026 | 16.26 |
| August 06, 2026 | 15.34 |
| August 05, 2026 | 16.17 |
| August 04, 2026 | 13.98 |
| August 03, 2026 | 14.21 |
| July 31, 2026 | 12.87 |
| July 30, 2026 | 12.84 |
| July 29, 2026 | 12.02 |
| July 28, 2026 | 12.45 |
| July 27, 2026 | 12.17 |
| July 24, 2026 | 12.69 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.370 |
| Intellia Therapeutics, Inc. | 2.359 |
| Prime Medicine, Inc. | 13.53 |
| Absci Corp. | 7.716 |
| 10X Genomics, Inc. | 14.76 |
Price to Book Value Related Metrics
| PS Ratio | 26.83 |
| PEG Ratio | -1.596 |
| Price | 188.67 |
| Earnings Yield | -1.18% |
| Market Cap | 11.82B |
| PEGY Ratio | -1.596 |